We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Oceaneering
OII
$5.25B
| $5.27M | 0.09% |
73,350
-354,366
| -83% | -$25.4M |
|
|
AIV
252
Aimco
AIV
$380M
| $5.26M | 0.09% |
+1,306,334
| New | +$5.01M |
|
|
IQNT
253
DELISTED
Inteliquent, Inc.
IQNT
| $5.25M | 0.09% |
361,100
-20,030
| -5% | -$250K |
|
254
FedEx
FDX
$74.5B
| $5.23M | 0.09% |
39,463
+30,263
| +329% | +$4.11M |
|
|
DATA
255
DELISTED
Tableau Software, Inc.
DATA
| $5.13M | 0.09% |
67,480
+25,860
| +62% | +$2.18M |
|
|
RAD
256
DELISTED
Rite Aid Corporation
RAD
| $5.13M | 0.09% |
40,910
+8,735
| +27% | +$1.06M |
|
257
Cracker Barrel
CBRL
$1.2B
| $5.09M | 0.09% |
52,371
-148,999
| -74% | -$15M |
|
258
WisdomTree
WT
$2.97B
| $5.07M | 0.08% |
386,450
+375,050
| +3,290% | +$5.73M |
|
|
SEE
259
DELISTED
Sealed Air
SEE
| $5.06M | 0.08% |
153,804
+140,004
| +1,015% | +$4.56M |
|
|
AVP
260
DELISTED
Avon Products, Inc.
AVP
| $4.89M | 0.08% |
+334,333
| New | +$5.14M |
|
|
INFN
261
DELISTED
Infinera Corporation Common Stock
INFN
| $4.88M | 0.08% |
537,501
+424,501
| +376% | +$3.72M |
|
262
Vertex Pharmaceuticals
VRTX
$121B
| $4.87M | 0.08% |
+68,920
| New | +$5.46M |
|
|
SYA
263
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $4.86M | 0.08% |
245,430
-33,070
| -12% | -$639K |
|
264
Itron
ITRI
$3.73B
| $4.83M | 0.08% |
136,022
+25,603
| +23% | +$970K |
|
|
DRIV
265
DELISTED
DIGITAL RIVER INC.
DRIV
| $4.81M | 0.08% |
275,800
-8,700
| -3% | -$154K |
|
266
Matrix Service
MTRX
$347M
| $4.79M | 0.08% |
141,678
+57,832
| +69% | +$1.73M |
|
267
Under Armour
UAA
$3B
| $4.78M | 0.08% |
+168,109
| New | +$4.36M |
|
268
Unisys
UIS
$227M
| $4.78M | 0.08% |
+156,930
| New | +$5.06M |
|
269
Cigna
CI
$76.6B
| $4.76M | 0.08% |
+56,880
| New | +$4.68M |
|
270
Liberty Global Class C
LBTYK
$3.27B
| $4.75M | 0.08% |
+144,228
| New | +$4.82M |
|
271
Hyster-Yale Materials Handling
HY
$593M
| $4.7M | 0.08% |
48,169
-4,050
| -8% | -$381K |
|
272
Emergent Biosolutions
EBS
$375M
| $4.61M | 0.08% |
182,243
-7,510
| -4% | -$190K |
|
|
NFX
273
DELISTED
Newfield Exploration
NFX
| $4.53M | 0.08% |
+144,333
| New | +$3.81M |
|
274
Ribbon Communications
RBBN
$354M
| $4.51M | 0.08% |
267,515
-2,512
| -0.9% | -$41.8K |
|
|
RKT
275
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $4.46M | 0.07% |
84,568
-125,080
| -60% | -$6.55M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.